Proteomics Global Market - Forecast to 2026

Publishing Date : February, 2020
Report Code : HCBT0116
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Proteomics is practically intricate as it includes the analysis and categorization including expression, structure, function, interaction, modification of overall protein signatures of a genome. Proteomics is gaining popularity as they are rendered crucial for early disease diagnosis, prognosis and monitor disease progression; personalized medicine along with playing a vital role in discovery and development of target molecules.

As estimated by IQ4I Research, the proteomics global market is expected to reach $27,670.3 million by 2026 growing at double digit CAGR from 2019 to 2026 due to increasing instance of chronic diseases, outbreak of new infectious diseases, technological innovations, increased need of personalized medicine, biomarker discovery and crop improvement research. The proteomics market is further segmented into product, application, end-user and geography.

By products, proteomics is segmented into instruments, consumables, software & services and proteomics services. Among products, the consumable accounted for the largest revenue; Consumables are further sub-segmented into Chromatography consumables, Electrophoresis consumables, Spectrometry consumables, Blotting consumables, Protein microarray consumables, X-Ray crystallography consumables and other consumables. Among consumables, spectrometry consumables sub-segment accounted for the largest revenue of  due to increased use in protein identification & characterization, followed by chromatography and electrophoresis consumables which is attributed to the increasing research and advancements in the field of proteomics.

Proteomics instruments market is segmented based on product type into Chromatography, Spectroscopy, Electrophoresis, Blotting, Protein microarrays, Flow cytometry, X-ray crystallography, Surface Plasmon resonance and others. Among the instruments, spectrometry instrument accounted for the largest revenue, protein microarray segment is expected to grow with double digit CAGR from 2019 to 2026.

Software and services market is estimated to be XX million in 2019 and is expected grow at double digit CAGR from 2019 to 2026. Proteomics service market is segmented into sample preparation and purification, characterization and quantification. Among the proteomics service market characterization segment accounted for the largest revenue in 2019 and is expected to grow at a strong mid teen CAGR from 2019 to 2026. The factors driving the market are raising use of proteomics in drug discovery, development and manufacturing, increasing demand for personalized medicine, early disease detection, diagnosis and treatment, technological advancements favoring adoption of proteomics, growing availability of funds for research, whereas, factors such as high cost of instruments and special research materials such as antibodies, tags etc., reproducibility of result,  lack of standardized workflow, problems in maintaining consistency,  complexity, lack of skilled professionals & data management options, ethical concern and regulatory issues are restraining the market growth.

By Application, the proteomics global market is segmented into protein biomarker discovery, drug discovery, development & manufacturing, diagnostics, plant proteomics and others. Among Applications, drug discovery, development & manufacturing accounted for the largest revenue in 2019 and is expected grow at double digit CAGR from 2019 to 2026 due to increasing interest in biomarker discovery and biologic drugs, increasing need of early diagnosis, advancements in proteomic technologies. Protein biomarker discovery application is expected to grow with the mid teen CAGR from 2019 to 2026. The growth is attributed to the increased fund release for discovery of protein biomarkers for various difficult to cure diseases such as cancer and neurodegenerative diseases.

By End-user, the proteomics global market is segmented into pharma & biotech, CROs, diagnostic companies and academic & research institutions. Among End-users, Pharma & Biotech accounted for the largest revenue in 2019 & CROs segment is expected to grow with a strong early teen CAGR from 2019 to 2026. This is attributed to the increased outsourcing activities in the developing regions in order to reduce the investment and increase productivity.

By Geography, the proteomics global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, South Korea and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & others). Among this, North America region accounted for the largest revenue in 2019 and is expected to grow at early double digit CAGR from 2019 to 2026 due to high technological advancements, increased growing awareness towards importance of protein research, increased biologics drug pipeline, investments and funds, increased onset of chronic diseases, outburst of new infectious diseases in diseases, increased interest towards personalized medicine/precision medicine in North America are boosting the market of proteomics.

The Asia-Pacific is the fastest growing region in 2019 and is expected to grow at early teen CAGR from 2019 to 2026 due to rising incidences of chronic diseases like cancer, cardio vascular disease, CNS etc. emergence and recurrent outbreaks of new infectious disease making Asia-Pacific region hot spot, government initiatives to increase awareness about proteomic technologies, increasing high acceptance of technological advancements, increased CROs offering proteomics services, are driving the proteomics market in this region. The proteomics global market is consolidated and all the existing players in this market are involved in developing new and advanced technologies to maintain their market shares and emerging companies are coming up with novel techniques and products for their growth.

Some of the major players in Proteomics market include Thermo Fisher Scientific (U.S.), Danaher Corporation. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Perkin Elmer, Inc. (U.S.), Bruker Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.S.), Waters Corporation (U.S.) Abcam (U.K.), Agilent Technologies (U.S.) and PerkinElmer (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • France
  • U.K.
  • Rest of Europe
  • Asia-Pacific 
  • Japan
  • China
  • South Korea
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East and Others

 

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
    • 2.7     PROTEOMICS APPROACHES
      • 2.7.1     INTRODUCTION
        • 2.7.1.1     BOTTOM UP APPROACH (SHOTGUN PROTEOMICS)
        • 2.7.1.2     TOP DOWN APPROACH
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     RISING USE OF PROTEOMICS IN DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING
        • 3.3.1.2     INCREASING DEMAND FOR PERSONALIZED MEDICINE
        • 3.3.1.3     EARLY DISEASE DETECTION, DIAGNOSIS AND TREATMENT
        • 3.3.1.4     TECHNOLOGICAL ADVANCEMENTS FAVORING ADOPTION OF PROTEOMICS
        • 3.3.1.5     GROWING AVAILABILITY OF FUNDS FOR RESEARCH
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     HIGH COST OF INSTRUMENTS AND SPECIAL RESEARCH MATERIALS
        • 3.3.2.2     MAINTAINING CONSISTENCY, REPRODUCIBILITY OF RESULT, LACK OF STANDARDIZATION, COMPLEXITY
        • 3.3.2.3     LACK OF SKILLED PROFESSIONALS AND DATA MANAGEMENT OPTIONS
        • 3.3.2.4     DATA SECURITY AND REGULATORY ISSUES
    • 3.4     SELECTED PRODUCTS AND SERVICE PRICE LIST
    • 3.5     REGULATORY AFFAIRS
      • 3.5.1     NORTH AMERICA
      • 3.5.2     EUROPE
      • 3.5.3     CHINA
      • 3.5.4     JAPAN
      • 3.5.5     SOUTH KOREA
      • 3.5.6     BRAZIL
    • 3.6     TECHNOLOGICAL ADVANCEMENTS
      • 3.6.1     INTRODUCTION
      • 3.6.2     ADVACEMENTS IN 4D PROTEOMICS
      • 3.6.3     ADVANCEMENTS IN CRYO ELECTRON MICROSCOPES
      • 3.6.4     ADVANCEMENTS IN CAPILLARY ELECTROPHORESIS
      • 3.6.5     ADVANCEMENTS IN LABEL FREE QUANTIFICATION
      • 3.6.6     ADVANCEMENTS IN MACHINE LEARNING
    • 3.7     PORTER’S FIVE FORCE ANALYSIS
      • 3.7.1     THREAT OF NEW ENTRANTS
      • 3.7.2     THREAT OF SUBSTITUTES
      • 3.7.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.7.4     BARGAINING POWER OF SUPPLIERS
      • 3.7.5     BARGAINING POWER OF BUYERS
    • 3.8     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.8.1     PROTEOMICS GLOBAL MARKET SHARE ANALYSIS
  • 4     PROTEOMICS GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     INSTRUMENTS
      • 4.2.1     SPECTROMETRY
      • 4.2.2     CHROMATOGRAPHY
      • 4.2.3     PROTEIN MICROARRAYS
      • 4.2.4     ELECTROPHORESIS
      • 4.2.5     X-RAY CRYSTALLOGRAPHY
      • 4.2.6     BLOTTING
      • 4.2.7     SURFACE PLASMON RESONANCE(SPR)
      • 4.2.8     FLOW CYTOMETRY
      • 4.2.9     OTHERS
    • 4.3     CONSUMABLES
      • 4.3.1     SPECTROMETRY CONSUMABLES
      • 4.3.2     CHROMATOGRAPHY CONSUMABLES
      • 4.3.3     ELECTROPHORESIS CONSUMABLES
      • 4.3.4     X-RAY CRYSTALLOGRAPHY CONSUMABLES
      • 4.3.5     BLOTTING CONSUMABLES
      • 4.3.6     PROTEIN MICROARRAY CONSUMABLES
      • 4.3.7     OTHER CONSUMABLES
    • 4.4     SOFTWARE AND SERVICES
    • 4.5     PROTEOMIC SERVICES
      • 4.5.1     PROCESS TYPE
        • 4.5.1.1     SAMPLE PREPARATION AND PURIFICATION
        • 4.5.1.2     PROTEIN CHARACTERIZATION
        • 4.5.1.3     PROTEIN QUANTIFICATION
  • 5     PROTEOMICS GLOBAL MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     PROTEIN BIOMARKER DISCOVERY
    • 5.3     DISCOVERY, DEVELOPMENT AND MANUFACTURING
    • 5.4     DIAGNOSTICS
    • 5.5     PLANT PROTEOMICS
    • 5.6     OTHERS
  • 6     PROTEOMICS GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     PHARMA BIOTECH
    • 6.3     CONTRACT RESEARCH ORGANIZATIONS
    • 6.4     ACADEMIC AND RESEARCH INSTITUTES
    • 6.5     DIAGNOSTIC COMPANIES
  • 7     PROTEOMICS GLOBAL MARKET, BY REGION
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     U.K
      • 7.3.3     FRANCE
      • 7.3.4     REST OF EUROPE
    • 7.4     ASIA-PACIFIC
      • 7.4.1     CHINA
      • 7.4.2     JAPAN
      • 7.4.3     SOUTH KOREA
      • 7.4.4     REST OF APAC
    • 7.5     REST OF THE WORLD
    • 7.6     BRAZIL
    • 7.7     REST OF LATIN AMERICA
    • 7.8     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     NEW PRODUCT LAUNCH
    • 8.3     AGREEMENTS, PARTERNERSHIPS AND COLLABORATIONS
    • 8.4     APPROVAL
    • 8.5     ACQUISITION
    • 8.6     OTHERS
  • 9     COMPANY PROFILES
    • 9.1     ABCAM PLC.
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     AGILENT TECHNOLOGIES
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     BECTON, DICKINSON AND COMPANY
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     BIO-RAD LABORATORIES
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     RODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     BRUKER CORPORATION
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     DANAHER CORPORATION
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     GENERAL ELECTRICAL COMPANY
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     MERCK KGAA
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     PERKINELMER, INC.
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     THERMO FISHER SCIENTIFIC INC.
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS
    • 9.11     WATERS CORPORATION
      • 9.11.1     OVERVIEW
      • 9.11.2     FINANCIALS
      • 9.11.3     PRODUCT PORTFOLIO
      • 9.11.4     KEY DEVELOPMENTS
      • 9.11.5     BUSINESS STRATEGY
      • 9.11.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 2     PROTEOMICS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 3     PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 4     INSTRUMENTS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
      • TABLE 5     INSTRUMENTS GLOBAL MARKET REVENUE, BY REGIONS, (2018-2026) ($MN)
      • TABLE 6     SPECTROMETRY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 7     CHROMATOGRAPY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 8     PROTEIN MICROARRAY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 9     ELECTROPHOREIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 10     X-RAY CRYSTALLOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 11     BLOTTING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 12     SURFACE PLASMON RESONANCE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 13     FLOW CYTOMETRY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 14     OTHER INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 15     CONSUMABLES GLOBAL MARKET REVENUE, BY INSTRUMENT TYPE, (2018-2026) ($MN)
      • TABLE 16     CONSUMABLES GLOBAL MARKET REVENUE, BY REGIONS, (2018-2026) ($MN)
      • TABLE 17     SPECTROMETRY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 18     CHROMATOGRAPHY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 19     ELECTROPHORESIS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 20     X-RAY CRYSTALLOGRAPHY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 21     BLOTTING CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 22     PROTEIN MICROARRAY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 23     OTHER CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 24     SOFTWARE AND SERVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 25     PROTEOMIC SERVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 26     PROTEOMIC SERVICES GLOBAL MARKET REVENUE, BY PROCESS TYPE, (2018-2026) ($MN)
      • TABLE 27     SAMPLE PREPARATION AND PURIFICATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 28     CHARACTERIZATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 29     QUANTIFICATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 30     PROTEOMICS GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 31     PROTEIN BIOMARKER DISCOVERY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 32     DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 33     DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 34     PLANT PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 35     OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 36     PROTEOMICS GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
      • TABLE 37     PHARMA BIOTECH GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 38     CONTRACT RESEARCH ORGANIZATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 39     ACADEMIC & RESEARCH INSTITUTES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 40     DIAGNOSTIC COMPANIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 41     PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 42     NORTH AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 43     NORTH AMERICA CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
      • TABLE 44     NORTH AMERICA INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
      • TABLE 45     NORTH AMERICA PROTEOMICS MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
      • TABLE 46     NORTH AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • TABLE 47     NORTH AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
      • TABLE 48     EUROPE PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 49     EUROPE CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE, (2018-2026) ($MN)
      • TABLE 50     EUROPE INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 51     EUROPE PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE, (2018-2026) ($MN)
      • TABLE 52     EUROPE PROTEOMICS MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 53     EUROPE PROTEOMICS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 54     EUROPE PROTEOMICS MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 55     ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 56     ASIA-PACIFIC CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
      • TABLE 57     ASIA-PACIFIC INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
      • TABLE 58     ASIA-PACIFIC PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
      • TABLE 59     ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • TABLE 60     ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
      • TABLE 61     ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
      • TABLE 62     ROW PROTEOMICS MARKET REVENUE, BY PRODUCT (2018-2026) ($MN)
      • TABLE 63     ROW CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
      • TABLE 64     ROW INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
      • TABLE 65     ROW PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
      • TABLE 66     ROW PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • TABLE 67     ROW PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
      • TABLE 68     ROW PROTEOMICS MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
      • TABLE 69     NEW PRODUCT LAUNCH (2018-2019)
      • TABLE 70     AGREEMENTS, PARTNERSHIPS & COLLABORATIONS (2018-2019)
      • TABLE 71     APPROVALS (2018-2019)
      • TABLE 72     ACQUSITION(2018-2019)
      • TABLE 73     OTHERS (2018-2019)
      • TABLE 74     ABCAM : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 75     ABCAM: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 76     AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q3)) ($MN)
      • TABLE 77     AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q3)) ($MN)
      • TABLE 78     AGILENT TECHNOLOGIES: TOTAL REVENUE, BY REGION, (2017-2019(Q3)) ($MN)
      • TABLE 79     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q3)) ($MN)
      • TABLE 80     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q3)) ($MN)
      • TABLE 81     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, LIFE SCIENCE SEGMENT, (2017-2019(Q3)) ($MN)
      • TABLE 82     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY REGION, (2017-2019(Q3)) ($MN)
      • TABLE 83     BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q2)) ($MN)
      • TABLE 84     BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q2)) ($MN)
      • TABLE 85     BIO-RAD LABORATORIES: TOTAL REVENUE, BY REGION, (2017-2019(Q2)) ($MN)
      • TABLE 86     BRUKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 87     BRUKER COPERATION: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
      • TABLE 88     BRUKER CORPORATION: TOTAL REVENUE, BY SUB-SEGMENT, (2017-2019) ($MN)
      • TABLE 89     BRUKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 90     DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q2)) ($MN)
      • TABLE 91     DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q2)) ($MN)
      • TABLE 92     DANAHER CORPORATION: TOTAL REVENUE, BY REGION, (2017-2019(Q2)) ($MN)
      • TABLE 93     GENERAL ELECTRONIC COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 94     GENERAL ELECTRONIC COMPANY: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
      • TABLE 95     GENERAL ELECTRONIC COMPANY: HEALTHCARE BY SUB-SEGMENT, (2017-2019) ($MN)
      • TABLE 96     GENERAL ELECTRONIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 97     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 98     MERCK KGAA: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
      • TABLE 99     MERCK KGAA COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 100     PERKINELMER,INC. : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 101     PERKINELMER,INC.: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
      • TABLE 102     PERKINELMER,INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 103     THERMO FISHER SCIENTIFIC INC. : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 104     THERMO FISHER SCIENTIFIC INC.: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
      • TABLE 105     THERMO FISHER SCIENTIFIC INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 106     WATERS CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 107     WATERS CORPORATION: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
      • TABLE 108     WATERS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)

      LIST OF FIGURES

      • FIGURE 1     PROTEOMICS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: PROTEOMICS GLOBAL MARKET
      • FIGURE 3     PROTEOMICS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     PROTEOMICS GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     PROTEOMICS GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     PROTEOMICS APPROACH
      • FIGURE 7     PROTEOMICS GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 8     PROCESS IN PROTEOMICS
      • FIGURE 9     PROCESS AND APPLICATIONS OF PROTEOMICS
      • FIGURE 10     PROTEOMICS GLOBAL MARKET: PORTER’S FIVE FORCE ANALYSIS
      • FIGURE 11     PROTEOMICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 12     PROTEOMOICS GLOBAL MARKET SHARE, BY PRODUCTS (2019 V’S 2026) (%)
      • FIGURE 13     INSTRUMENTS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
      • FIGURE 14     INSTRUMENTS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 15     SPECTROMETRY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 16     CHROMATOGRAPHY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 17     PROTEIN MICROARRAY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 18     ELECTROPHORESIS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 19     X-RAY CRYSTALLOGRAPHY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 20     BLOTTING GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 21     SURFACE PLASMON RESONANCE GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 22     FLOWCYTOMETRY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 23     OTHERS INSTRUMENT GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 24     CONSUMABLES GLOBAL MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
      • FIGURE 25     CONSUMABLES MARKET SHARE BY REGION (2019 V’S 2026) (%)
      • FIGURE 26     SPECTROMETRY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 27     CHROMATOGRAPHY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 28     ELECTROPHORESIS CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 29     X-RAY CRYSTALLOGRAPHY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 30     BLOTTING CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 31     PROTEIN MICROARRAY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 32     OTHERS CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 33     SOFTWARE AND SERVICES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 34     PROTEOMIC SERVICES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 35     PROTEOMICS SERVICES GLOBAL MARKET SHARE, BY PROCESS TYPE (2019 V’S 2026) (%)
      • FIGURE 36     SAMPLE PREPARATION AND PURIFICATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 37     CHARACTERIZATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 38     QUANTIFICATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 39     PROTEOMICS GLOBAL MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
      • FIGURE 40     PROTEIN BIOMARKER DISCOVERY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 41     DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 42     DIAGNOSTICS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 43     PLANT PROTEOMICS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 44     OTHERS APPLICATIONS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 45     PROTEOMICS GLOBAL MARKET SHARE, BY END-USERS (2019 V’S 2026) (%)
      • FIGURE 46     PHARMA BIOTECH GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 47     CONTRACT RESEARCH ORGANIZATIONS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 48     ACADEMIC & RESEARCH INSTITUTES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 49     DIAGNOSTICS COMPANIES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
      • FIGURE 50     PROTEOMICS GLOBAL MARKET REVENUE, BY GEOGRAPHY (2018 - 2026) ($MN), CAGR (%)
      • FIGURE 51     PROTEOMICS GLOBAL MARKET REVENUE, BY REGION (2019) ($MN)
      • FIGURE 52     NORTH AMERICA PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
      • FIGURE 53     NORTH AMERICA CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
      • FIGURE 54     NORTH AMERICA INSTRUMENT MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
      • FIGURE 55     NORTH AMERICA PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
      • FIGURE 56     NORTH AMERICA PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
      • FIGURE 57     NORTH AMERICA PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
      • FIGURE 58     U.S. PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 59     U.S. PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 60     U.S. PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 61     U.S. PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 62     REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 63     REST OF NORTH AMERICA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 64     REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 65     REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 66     EUROPE PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
      • FIGURE 67     EUROPE CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
      • FIGURE 68     EUROPE INSTRUMNET MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
      • FIGURE 69     EUROPE PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
      • FIGURE 70     EUROPE PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
      • FIGURE 71     EUROPE PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
      • FIGURE 72     EUROPE PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
      • FIGURE 73      GERMANY PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 74     GERMANY PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 75     GERMANY PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 76     GERMANY PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 77     U.K PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 78     U.K PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 79     U.K. PROTEOMICS MARKET REVENUE, BY APPLICATION TYPE (2019 V’S 2026) ($MN)
      • FIGURE 80      U.K.PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 81     FRANCE PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 82     FRANCE PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 83     FRANCE PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 84     FRANCE PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 85     REST OF EUROPE PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 86     REST OF EUROPE PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 87     REST OF EUROPE PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 88     REST OF EUROPE PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 89     ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
      • FIGURE 90     ASIA-PACIFIC CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
      • FIGURE 91     ASIA-PACIFIC INSTRUMENT MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
      • FIGURE 92     ASIA-PACIFIC PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
      • FIGURE 93     ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
      • FIGURE 94     ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
      • FIGURE 95     ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
      • FIGURE 96     CHINA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 97     CHINA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 98     CHINA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 99     CHINA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 100     JAPAN PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 101     JAPAN PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 102     JAPAN PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 103     JAPAN PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 104     SOUTH KOREA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 105     SOUTH KOREA INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 106     SOUTH KOREA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 107     SOUTH KOREA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 108     REST OF APAC PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 109     REST OF APAC PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 110     REST OF APAC PROTEOMICS MARKET REVENUE, BY APPLICATION TYPE (2019 V’S 2026) ($MN)
      • FIGURE 111     REST OF APAC PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 112     REST OF THE WORLD PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 113     REST OF THE WORLD CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
      • FIGURE 114     REST OF THE WORLD INSTRUMNET MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
      • FIGURE 115     REST OF THE WORLD PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
      • FIGURE 116     REST OF THE WORLD PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
      • FIGURE 117     REST OF THE WORLD PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
      • FIGURE 118     REST OF THE WORLD PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
      • FIGURE 119     BRAZIL PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 120     BRAZIL PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 121     BRAZIL PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 122     BRAZIL PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 123     REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 124     REST OF LATIN AMERICA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 125     REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 126     REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 127     MIDDLE EAST AND OTHERS PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
      • FIGURE 128     MIDDLE EAST AND OTHERS PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
      • FIGURE 129     MIDDLE EAST AND OTHERS PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
      • FIGURE 130     REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
      • FIGURE 131     KEY GROWTH STRATEGIES (2018-2019)
      • FIGURE 132     OVERVIEW: ABCAM PLC
      • FIGURE 133     SWOT: ABCAM PLC.
      • FIGURE 134     OVERVIEW: AGILENT TECHNOLOGIES
      • FIGURE 135     SWOT: AGILENT TECHNOLOGIES
      • FIGURE 136     OVERVIEW: BECTON, DICKINSON AND COMPANY
      • FIGURE 137     SWOT: BECTON, DICKINSON AND COMPANY
      • FIGURE 138     OVERVIEW: BIO-RAD LABORATORIES
      • FIGURE 139     SWOT: BIO-RAD LABORATORIES
      • FIGURE 140     OVERVIEW: BRUKER CORPORATION
      • FIGURE 141     SWOT: BRUKER CO-OPERATION
      • FIGURE 142     OVERVIEW: DANAHER CORPORATION
      • FIGURE 143     SWOT: DANAHER CORPORATION
      • FIGURE 144     OVERVIEW: GENERAL ELECTRICAL COMPANY
      • FIGURE 145     SWOT: GENERAL ELECTRONIC COMPANY
      • FIGURE 146     OVERVIEW: MERCK KGAA
      • FIGURE 147     SWOT: MERCK KGAA CORPORATION
      • FIGURE 148     OVERVIEW: PERKIN ELMER, INC.
      • FIGURE 149     SWOT: PERKIN ELMER, INC.
      • FIGURE 150     OVERVIEW: THERMO FISHER SCIENTIFIC INC.
      • FIGURE 151     SWOT: THERMO FISHER SCIENTIFIC
      • FIGURE 152     OVERVIEW: WATERS CORPORATION
      • FIGURE 153     SWOT: WATERS CORPORATION

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABBIOTEC LLC
      • 2     ABCAM PLC.
      • 3     ABFRONTIER CO., LTD
      • 4     ABNOVA CORPORATION
      • 5     ABSOLUTE ANTIBODY LTD
      • 6     ACROBIOSYSTEMS
      • 7     ACTIVE MOTIF, INC.
      • 8     ADALTIS S.R.L.
      • 9     ADVANCED BIOSCIENCE LABORATORIES INC.
      • 10     ADVANSTA INC.
      • 11     ADVION, INC.
      • 12     AFFILOGIC
      • 13     AFFINITY BIOSCIENCES
      • 14     AGAROSE BEAD TECHNOLOGIES
      • 15     AGILENT TECHNOLOGIES INC.
      • 16     AGRISERA
      • 17     AKESOGEN, INC.
      • 18     ALPCO DIAGNOSTICS
      • 19     ALPHA DIAGNOSTIC INTL. INC.
      • 20     ALPHALYSE, INC.
      • 21     AMETEK, INC.
      • 22     ANALYTIK JENA
      • 23     APPLIED BIOMICS, INC.
      • 24     APPLIED PHOTOPHYSICS LIMITED.
      • 25     ASYMCHEM LABORATORIES INC.
      • 26     AVIVA SYSTEMS BIOLOGY CORP
      • 27     AVOMEEN ANALYTICAL SERVICES
      • 28     AXIL SCIENTIFIC PTE LTD.
      • 29     AXISPHARM LABORATORIES LTD.
      • 30     BEANTOWN BIOTECH
      • 31     BECTON, DICKINSON AND COMPANY
      • 32     BERGMANN MESSGERÄTE ENTWICKLUNG KG
      • 33     BERTHOLD TECHNOLOGIES GMBH & CO. KG
      • 34     BGI GROUP INC.
      • 35     BIO X CELL
      • 36     BIOCHAIN INSTITUTE INC.
      • 37     BIOGNOSYS AG
      • 38     BIOINFORMATICS SOLUTIONS, INC.
      • 39     BIOPROXIMITY LLC
      • 40     BIO-RAD LABORATORIES, INC.
      • 41     BIORBYT
      • 42     BIORESOURCE BIOTECH PVT. LTD.
      • 43     BIOSENSING INSTRUMENT, INC.
      • 44     BIOSS ANTIBODIES
      • 45     BIO-TECHNE
      • 46     BIOTOOLS CO., LTD.
      • 47     BIOTREND CHEMIKALIEN GMBH
      • 48     BIOVISION
      • 49     BIO-XTAL
      • 50     BMG LABTECH
      • 51     BON OPUS BIOSCIENCES LLC
      • 52     BOSTER BIOLOGICAL TECHNOLOGY
      • 53     BPS BIOSCIENCE INC.
      • 54     BRUKER CORPORATION
      • 55     CALIXAR SAS
      • 56     CAPITALBIO TECHNOLOGY CO., LTD.
      • 57     CAPRION PROTEOMICS INC.
      • 58     CAYMAN CHEMICAL COMPANY
      • 59     CELL MICROSYSTEMS, INC.
      • 60     CELL SIGNALING TECHNOLOGY
      • 61     CHARLES RIVER LABORATORIES
      • 62     CHROMOTEK GMBH
      • 63     CHROMOUS BIOTECH PVT. LTD.
      • 64     CIC BIOGUNE
      • 65     CIRA DISCOVERY SCIENCES INC
      • 66     CLEAVER SCIENTIFIC LTD
      • 67     CORIOLIS PHARMA RESEARCH GMBH
      • 68     COSMO BIO CO., LTD.
      • 69     COVANCE INC
      • 70     CREATIVE BIOMART
      • 71     CREATIVE BIOSTRUCTRUE
      • 72     CREATIVE PROTEOMICS
      • 73     CRELUX GMBH
      • 74     CUBE BIOTECH GMBH
      • 75     DANAHER CORPORATION.
      • 76     DB BIOTECH, SPOL. S R.O.
      • 77     JASCO CORPORATION
      • 78     JEOL LTD.
      • 79     JUBILANT BIOSYS LIMITED
      • 80     KNAUER WISSENSCHAFTLICHE GERÄTE GMBH
      • 81     LABGENE SCIENTIFIC SA
      • 82     LABNET INTERNATIONAL, INC.
      • 83     LC SCIENCES LLC
      • 84     LI-COR BIOSCIENCES INC
      • 85     LIFESENSORS, INC
      • 86     LIFESPAN BIOSCIENCES, INC
      • 87     LONZA GROUP AG
      • 88     LUMINEX COPERATION
      • 89     LUNGINNOV S.A.S
      • 90     MALVERN INSTRUMENTS
      • 91     MBL INTERNATIONAL CORPORATION
      • 92     MERCK KGAA
      • 93     MILTENYI BIOTEC
      • 94     MITEGEN, LLC
      • 95     MKS INSTRUMENTS, INC.
      • 96     MOLECULAR INNOVATIONS INC.
      • 97     MP BIOMEDICALS LLC
      • 98     MRM PROTEOMICS INC.
      • 99     MS BIOWORKS, LLC
      • 100     MTOZ BIOLABS, INC
      • 101     NACALAI TESQUE, INC
      • 102     NANOCELLECT BIOMEDICAL, INC.
      • 103     NEUROMICS, INC.
      • 104     NEXCELOM BIOSCIENCE
      • 105     NMI TT PHARMASERVICES
      • 106     NOVATEIN BIOSCIENCES, INC.
      • 107     NOVUS BIOLOGICALS LLC
      • 108     OCEAN OPTICS INC
      • 109     ORIGENE TECHNOLOGIES, INC.
      • 110     OXFORD INSTRUMENTS PLC
      • 111     OY MEDIX BIOCHEMICA AB
      • 112     PARALLEX BIOASSAYS INC.
      • 113     PBL ASSAY SCIENCE
      • 114     PEAK PROTEINS LTD
      • 115     PERKIN ELMER, INC.
      • 116     PHENOSWITCH BIOSCIENCE
      • 117     POOCHON SCIENTIFIC LLC
      • 118     PRECISION BIOLOGICS, INC.
      • 119     PROBIOGEN AG
      • 120     PROFI PROTEOMICS
      • 121     PROMEGA CORPORATION
      • 122     PROMISE ADVANCED PROTEOMICS
      • 123     PROSPEC, INC.
      • 124     PROTAGEN PROTEIN SERVICES GMBH
      • 125     PROTEINONE LLC
      • 126     PROTEINTECH GROUP
      • 127     PROTEOME FACTORY AG
      • 128     PROTEOMEDIX AG
      • 129     PROTEOMICS INTERNATIONAL LABORATORIES
      • 130     PROTEONA PTE. LTD.
      • 131     PROTEROS BIOSTRUCTURES GMBH
      • 132     QED BIOSCIENCE, INC
      • 133     QIAGEN, INC
      • 134     QUARTZ BIO SA
      • 135     R&D SYSTEMS, INC.
      • 136     RANDOX LIFE SCIENCES LTD.
      • 137     RAYBIOTECH LIFE, INC.
      • 138     REICHERT TECHNOLOGIES LIFE SCIENCES,
      • 139     RENISHAW PLC
      • 140     RIGAKU COPORATION
      • 141     ROCHE HOLDING AG
      • 142     ROCKLAND IMMUNOCHEMICALS, INC.
      • 143     SANDOR MEDICAIDS PVT LTD
      • 144     SANTA CRUZ BIOTECHNOLOGY, INC.
      • 145     SAROMICS BIOSTRUCTURES AB
      • 146     SCRIPPS RESEARCH
      • 147     SDI GROUP PLC
      • 148     SERIMMUNE, INC.
      • 149     SERVA ELECTROPHORESIS GMBH
      • 150     SGS LIFESCIENCE
      • 151     SHANGHAI MEDICILON INC
      • 152     SHIMADZU SCIENTIFIC INSTRUMENTS, INC.
      • 153     SIGNAL CHEM PHARMACEUTICALS INC
      • 154     SILVER LAKE RESEARCH CORP
      • 155     SOMALOGIC INC.
      • 156     SOMRU BIOSCIENCE INC.
      • 157     ST JOHN'S LABORATORY LTD
      • 158     STEMCELL TECHNOLOGIES
      • 159     STRESSMARQ BIOSCIENCES INC.
      • 160     SYD LABS, INC.
      • 161     SYNAPTIC SYSTEMS GMBH
      • 162     SYSTEM BIOSCIENCES, LLC
      • 163     TAKARA BIO INC.
      • 164     TEBU-BIO SAS
      • 165     THE BINDING SITE GROUP LTD.
      • 166     THERMO FISHER SCIENTIFIC INC.
      • 167     TOSOH BIOSCIENCE, INC.
      • 168     TOYOBO CO., LTD.
      • 169     TRANSGEN BIOTECH CO., LTD
      • 170     TRENZYME GMBH
      • 171     TULIP BIOLABS, INC:
      • 172     TURKU BIOSCIENCE
      • 173     UNITED STATES BIOLOGICAL INC.
      • 174     VECTOR LABORATORIES, INC.
      • 175     VPROTEOMICS
      • 176     WATERS CORPORATION
      • 177     WUXI GALAK CHROMATOGRAPHY TECHNOLOGY CO., LTD
      • 178     XCELRIS LABS LTD.
      • 179     YMC CO., LTD.
      • 180     YO PROTEINS AB